Cover Page - shares
|
9 Months Ended |
|
Sep. 30, 2020 |
Nov. 10, 2020 |
| Cover [Abstract] |
|
|
| Document Type |
10-Q
|
|
| Document Quarterly Report |
true
|
|
| Document Period End Date |
Sep. 30, 2020
|
|
| Document Transition Report |
false
|
|
| Entity File Number |
001-33637
|
|
| Entity Registrant Name |
Cumberland Pharmaceuticals Inc.
|
|
| Entity Central Index Key |
0001087294
|
|
| Current Fiscal Year End Date |
--12-31
|
|
| Document Fiscal Year Focus |
2020
|
|
| Document Fiscal Period Focus |
Q2
|
|
| Amendment Flag |
false
|
|
| Entity Incorporation, State or Country Code |
TN
|
|
| Entity Tax Identification Number |
62-1765329
|
|
| Entity Address, Address Line One |
2525 West End Avenue
|
|
| Entity Address, Address Line Two |
Suite 950
|
|
| Entity Address, City or Town |
Nashville
|
|
| Entity Address, State or Province |
TN
|
|
| Entity Address, Postal Zip Code |
37203
|
|
| City Area Code |
615
|
|
| Local Phone Number |
255-0068
|
|
| Entity Current Reporting Status |
Yes
|
|
| Entity Interactive Data Current |
Yes
|
|
| Entity Filer Category |
Non-accelerated Filer
|
|
| Entity Small Business |
true
|
|
| Entity Emerging Growth Company |
false
|
|
| Entity Shell Company |
false
|
|
| Title of 12(b) Security |
Common stock, no par value
|
|
| Trading Symbol |
CPIX
|
|
| Security Exchange Name |
NASDAQ
|
|
| Entity Common Stock, Shares Outstanding |
|
15,036,923
|